MIRM

Mirum Pharmaceuticals, Inc.

32.95 USD
-0.05 (-0.15%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Mirum Pharmaceuticals, Inc. stock is up 30.24% since 30 days ago. The next earnings date is Aug 1, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 60% of the previous 4 June’s closed higher than May. 100% of analysts rate it a buy.

About Mirum Pharmaceuticals, Inc.

Mirum Pharmaceuticals, Inc. focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease.

  • HC Wainwright & Co.
    Fri Jun 7, 07:09
    buy
    confirm
  • HC Wainwright & Co.
    Mon Jun 3, 06:39
    buy
    confirm